Dr. William H. Tettelbach graduated from The University of Tennessee School of
Medicine in 1995. He completed his Internal Medicine residency and Infectious
Diseases fellowship, as well as formal training in Biomedical Informatics, at
the University of Utah. He currently is board certified in Undersea &
Hyperbaric Medicine, Infectious Diseases, Internal Medicine, and retains an
academic appointment at Duke University School of Medicine. From 2000 to 2003
he served as Medical Director for TheraDoc, a provider of electronic clinical
surveillance to healthcare organizations, and provided subject matter expertise
for the development of their "Antibiotic Assistant," 'Infection Control
Assistant," and "Adverse Drug Event Assistant." These integrated clinical
surveillance/decision support software modules have helped to improve the
quality and safety of patient care and are now utilized in over 1100 hospitals
across the nation.
While in practice within the Methodist Le Bonheur Healthcare system in Memphis, Dr. Tettelbach was acting Medical Director of Wound Care and Hyperbaric Medicine outpatient/inpatient services. He successfully opened the systems first wound care center that offered hyperbaric oxygen therapy as well as restructured the Methodist North Hospital’s inpatient wound care teams which positively reduced the average length of stay in patients with active wounds and reduced the incidence of hospital acquired ulcers. Dr. Tettelbach was invited to participate in the response to The Surviving Sepsis Campaign, a global initiative to bring together professional organizations to reduce mortality from sepsis and, as a result, led the development of a Cerner rules-based electronic "sepsis alert" module. Since its successful development, the now labeled “St. John’s agent" has been adopted by other healthcare systems such as Toronto East General Hospital in Canada, the Henry Ford Medical Center in Detroit, Michigan, the University of Alabama at Birmingham Health Center and the Intermountain Healthcare system in Utah.